{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:06:27Z","timestamp":1790805987460,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1124\/jpet.104.078113","type":"journal-article","created":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T03:22:44Z","timestamp":1108437764000},"page":"1020-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"title":["Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid"],"prefix":"10.1016","volume":"312","author":[{"given":"Sean C.","family":"Semple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy O.","family":"Harasym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy A.","family":"Clow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Klimuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.078113_bib1","doi-asserted-by":"crossref","unstructured":"Allen TM and Hansen C (1991) Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1068: 133\u2013141.","DOI":"10.1016\/0005-2736(91)90201-I"},{"key":"10.1124\/jpet.104.078113_bib2","doi-asserted-by":"crossref","unstructured":"Alving CR (1992) Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens. Biochim Biophys Acta 1113: 307\u2013322.","DOI":"10.1016\/0304-4157(92)90004-T"},{"key":"10.1124\/jpet.104.078113_bib3","doi-asserted-by":"crossref","unstructured":"Aragnol D and Leserman LD (1986) Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc Natl Acad Sci USA 83: 2699\u20132703.","DOI":"10.1073\/pnas.83.8.2699"},{"key":"10.1124\/jpet.104.078113_bib4","doi-asserted-by":"crossref","unstructured":"Bakker-Woudenberg IAJM and van Etten EWM (1998) Medical Applications of Liposomes (Lasic DD and Papahadjopoulos D eds) pp 181\u2013188, Elsevier Science B.V., Amsterdam.","DOI":"10.1016\/B978-044482917-7\/50011-9"},{"key":"10.1124\/jpet.104.078113_bib5","doi-asserted-by":"crossref","unstructured":"Boerman OC, Oyen WJ, van Bloois L, Koenders EB, van der Meer JW, Corstens FH, and Storm G (1997) Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. J Nucl Med 38: 489\u2013493.","DOI":"10.1136\/ard.56.6.369"},{"key":"10.1124\/jpet.104.078113_bib6","doi-asserted-by":"crossref","unstructured":"Cheng TL, Wu PY, Wu MF, Chern JW, and Roffler SR (1999) Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. Bioconjug Chem 10: 520\u2013528.","DOI":"10.1021\/bc980143z"},{"key":"10.1124\/jpet.104.078113_bib7","doi-asserted-by":"crossref","unstructured":"Chonn A, Semple SC, and Cullis PR (1992) Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem 267: 18759\u201318765.","DOI":"10.1016\/S0021-9258(19)37026-7"},{"key":"10.1124\/jpet.104.078113_bib8","doi-asserted-by":"crossref","unstructured":"Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, and Boerman OC (2000) Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 292: 1071\u20131079.","DOI":"10.1016\/S0022-3565(24)35391-1"},{"key":"10.1124\/jpet.104.078113_bib9","doi-asserted-by":"crossref","unstructured":"Freimer ML, McIntosh K, Adams RA, Alving CR, and Drachman DB (1993) Gangliosides elicit a T-cell independent antibody response. J Autoimmun 6: 281\u2013289.","DOI":"10.1006\/jaut.1993.1024"},{"key":"10.1124\/jpet.104.078113_bib10","doi-asserted-by":"crossref","unstructured":"Goins B, Phillips WT, and Klipper R (1998) Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal. J Liposome Res 8: 265\u2013281.","DOI":"10.3109\/08982109809035531"},{"key":"10.1124\/jpet.104.078113_bib11","doi-asserted-by":"crossref","unstructured":"Goren D and Gabizon A (1998) Medical Applications of Liposomes (Lasic DD and Papahadjopoulos D eds) pp 259\u2013274, Elsevier Science B.V., Amsterdam.","DOI":"10.1016\/B978-044482917-7\/50015-6"},{"key":"10.1124\/jpet.104.078113_bib12","doi-asserted-by":"crossref","unstructured":"Harding JA, Engbers CM, Newman MS, Goldstein NI, and Zalipsky S (1997) Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochim Biophys Acta 1327: 181\u2013192.","DOI":"10.1016\/S0005-2736(97)00056-4"},{"key":"10.1124\/jpet.104.078113_bib13","doi-asserted-by":"crossref","unstructured":"Harris JM, Martin NE, and Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40: 539\u2013551.","DOI":"10.2165\/00003088-200140070-00005"},{"key":"10.1124\/jpet.104.078113_bib14","doi-asserted-by":"crossref","unstructured":"Ishida T, Masuda K, Ichikawa T, Ichihara M, Irimura K, and Kiwada H (2003) Accelerated clearance of a second injection of PEGylated liposomes in mice. Int J Pharm 255: 167\u2013174.","DOI":"10.1016\/S0378-5173(03)00085-1"},{"key":"10.1124\/jpet.104.078113_bib15","doi-asserted-by":"crossref","unstructured":"Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709\u2013760.","DOI":"10.1146\/annurev.immunol.20.100301.064842"},{"key":"10.1124\/jpet.104.078113_bib16","unstructured":"Lasic DD, Vallner JJ, and Working PK (1999) Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther 1: 177\u2013185."},{"key":"10.1124\/jpet.104.078113_bib17","doi-asserted-by":"crossref","unstructured":"Laverman P, Carstens MG, Boerman OC, Dams ET, Oyen WJ, van Rooijen N, Corstens FH, and Storm G (2001) Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 298: 607\u2013612.","DOI":"10.1016\/S0022-3565(24)29419-2"},{"key":"10.1124\/jpet.104.078113_bib18","doi-asserted-by":"crossref","unstructured":"Levin AA (1999) A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim Biophys Acta 1489: 69\u201384.","DOI":"10.1016\/S0167-4781(99)00140-2"},{"key":"10.1124\/jpet.104.078113_bib19","doi-asserted-by":"crossref","unstructured":"Li WM, Bally MB, and Schutze-Redelmeier MP (2001) Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes. Vaccine 20: 148\u2013157.","DOI":"10.1016\/S0264-410X(01)00277-8"},{"key":"10.1124\/jpet.104.078113_bib20","doi-asserted-by":"crossref","unstructured":"Mitzutamari RK, Kremer LJ, Basile EA, and Nores GA (1998) Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy. J Neurosci Res 51: 237\u2013242.","DOI":"10.1002\/(SICI)1097-4547(19980115)51:2<237::AID-JNR12>3.0.CO;2-5"},{"key":"10.1124\/jpet.104.078113_bib21","unstructured":"Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF, and Crooke ST (1997) Immune stimulation\u2013a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des 12: 421\u2013432."},{"key":"10.1124\/jpet.104.078113_bib22","doi-asserted-by":"crossref","unstructured":"Mui B, Raney SG, Semple SC, and Hope MJ (2001) Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles. J Pharmacol Exp Ther 298: 1185\u20131192.","DOI":"10.1016\/S0022-3565(24)29491-X"},{"key":"10.1124\/jpet.104.078113_bib23","doi-asserted-by":"crossref","unstructured":"Oussoren C and Storm G (1999) Effect of repeated intravenous administration on the circulation kinetics of poly(ethyleneglycol)-liposomes in rats. J Liposome Res 9: 349\u2013355.","DOI":"10.3109\/08982109909018655"},{"key":"10.1124\/jpet.104.078113_bib24","doi-asserted-by":"crossref","unstructured":"Phillips NC and Dahman J (1995) Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids. Immunol Lett 45: 149\u2013152.","DOI":"10.1016\/0165-2478(94)00251-L"},{"key":"10.1124\/jpet.104.078113_bib25","doi-asserted-by":"crossref","unstructured":"Phillips NC and Emili A (1991) Immunogenicity of immunoliposomes. Immunol Lett 30: 291\u2013296.","DOI":"10.1016\/0165-2478(91)90040-H"},{"key":"10.1124\/jpet.104.078113_bib26","doi-asserted-by":"crossref","unstructured":"Richter AW and Akerblom E (1983) Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Int Arch Allergy Appl Immunol 70: 124\u2013131.","DOI":"10.1159\/000233309"},{"key":"10.1124\/jpet.104.078113_bib27","doi-asserted-by":"crossref","unstructured":"Richter AW and Akerblom E (1984) Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo and in healthy blood donors. Int Arch Allergy Appl Immunol 74: 36\u201339.","DOI":"10.1159\/000233512"},{"key":"10.1124\/jpet.104.078113_bib28","doi-asserted-by":"crossref","unstructured":"Semple SC, Klimuk SK, Harasym TO, and Hope MJ (2000) Lipid-based formulations of antisense oligonucleotides for systemic delivery applications. Methods Enzymol 313: 322\u2013341.","DOI":"10.1016\/S0076-6879(00)13020-4"},{"key":"10.1124\/jpet.104.078113_bib29","doi-asserted-by":"crossref","unstructured":"Senior J, Delgado C, Fisher D, Tilcock C, and Gregoriadis G (1991) Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062: 77\u201382.","DOI":"10.1016\/0005-2736(91)90337-8"},{"key":"10.1124\/jpet.104.078113_bib30","doi-asserted-by":"crossref","unstructured":"Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K, and Wagner H (1997) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 27: 1671\u20131679.","DOI":"10.1002\/eji.1830270712"},{"key":"10.1124\/jpet.104.078113_bib31","doi-asserted-by":"crossref","unstructured":"Stein CA and Krieg AM (1997) Antisense Technology: A Practical Approach (Lichtenstein C and Nellen W eds) pp 241\u2013264, Oxford University Press, New York.","DOI":"10.1093\/oso\/9780199635832.003.0011"},{"key":"10.1124\/jpet.104.078113_bib32","doi-asserted-by":"crossref","unstructured":"Stein Y, Halperin G, and Stein O (1980) Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat. FEBS Lett 111: 104\u2013106.","DOI":"10.1016\/0014-5793(80)80771-X"},{"key":"10.1124\/jpet.104.078113_bib33","doi-asserted-by":"crossref","unstructured":"Stuart DD, Semple SC, and Allen TM (2004) High efficiency entrapment of antisense oligonucleotides in liposomes. Methods Enzymol 387: 171\u2013188.","DOI":"10.1016\/S0076-6879(04)87011-3"},{"key":"10.1124\/jpet.104.078113_bib34","doi-asserted-by":"crossref","unstructured":"Tardi PG, Swartz EN, Harasym TO, Cullis PR, and Bally MB (1997) An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin. J Immunol Methods 210: 137\u2013148.","DOI":"10.1016\/S0022-1759(97)00178-6"},{"key":"10.1124\/jpet.104.078113_bib35","doi-asserted-by":"crossref","unstructured":"van Rooijen N and van Nieuwmegen R (1980) Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. Immunol Commun 9: 243\u2013256.","DOI":"10.3109\/08820138009065997"},{"key":"10.1124\/jpet.104.078113_bib36","doi-asserted-by":"crossref","unstructured":"Wang L, Prakash RK, Stein CA, Koehn RK, and Ruffner DE (2003) Progress in the delivery of therapeutic oligonucleotides: organ\/cellular distribution and targeted delivery of oligonucleotides in vivo. Antisense Nucleic Acid Drug Dev 13: 169\u2013189.","DOI":"10.1089\/108729003768247637"},{"key":"10.1124\/jpet.104.078113_bib37","doi-asserted-by":"crossref","unstructured":"Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, and Krieg AM (1997) Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA 94: 10833\u201310837.","DOI":"10.1073\/pnas.94.20.10833"},{"key":"10.1124\/jpet.104.078113_bib38","doi-asserted-by":"crossref","unstructured":"Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, and Cullis PR (1999) Stabilized plasmid-lipid particles: construction and characterization. Gene Ther 6: 271\u2013281.","DOI":"10.1038\/sj.gt.3300821"},{"key":"10.1124\/jpet.104.078113_bib39","doi-asserted-by":"crossref","unstructured":"Whitmore MM, Li S, Falo L Jr, and Huang L (2001) Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol Immunother 50: 503\u2013514.","DOI":"10.1007\/s002620100227"},{"key":"10.1124\/jpet.104.078113_bib40","doi-asserted-by":"crossref","unstructured":"Woodle MC (1998) Controlling liposome blood clearance by surface-grafted polymers. Adv Drug Deliv Rev 32: 139\u2013152.","DOI":"10.1016\/S0169-409X(97)00136-1"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.078113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:19:35Z","timestamp":1739999975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524318427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0022356524318427"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.078113","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.078113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}